Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8301120rdf:typepubmed:Citationlld:pubmed
pubmed-article:8301120lifeskim:mentionsumls-concept:C1440684lld:lifeskim
pubmed-article:8301120lifeskim:mentionsumls-concept:C0020971lld:lifeskim
pubmed-article:8301120lifeskim:mentionsumls-concept:C1332717lld:lifeskim
pubmed-article:8301120lifeskim:mentionsumls-concept:C1706438lld:lifeskim
pubmed-article:8301120lifeskim:mentionsumls-concept:C0039195lld:lifeskim
pubmed-article:8301120lifeskim:mentionsumls-concept:C0025252lld:lifeskim
pubmed-article:8301120lifeskim:mentionsumls-concept:C0085358lld:lifeskim
pubmed-article:8301120lifeskim:mentionsumls-concept:C1749467lld:lifeskim
pubmed-article:8301120lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:8301120lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:8301120lifeskim:mentionsumls-concept:C1413244lld:lifeskim
pubmed-article:8301120lifeskim:mentionsumls-concept:C2698600lld:lifeskim
pubmed-article:8301120lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:8301120lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:8301120lifeskim:mentionsumls-concept:C0456387lld:lifeskim
pubmed-article:8301120lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:8301120lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:8301120pubmed:issue3lld:pubmed
pubmed-article:8301120pubmed:dateCreated1994-3-9lld:pubmed
pubmed-article:8301120pubmed:abstractTextImmunization with soluble proteins only rarely induces a specific response of CD8+ CTL. We describe experiments that demonstrate the efficient and specific in vivo priming of CTL in BALB/c mice immunized with soluble hepatitis B virus (HBV)-derived surface (S) protein. A single (s.c., i.p. or i.v.) injection of a low dose (30 ng to 3 micrograms per mouse) of recombinant S protein particles without adjuvants induced a CTL response. This specific cytotoxic response was read out against a panel of different S protein-expressing transfected mouse cell lines. Effector cells of this response were Ld-restricted, CD3+ CD4- CD8+ CTL. H-2d/Ld+ (BALB/c, C.B-17) mice were responders; H-2d/Ld- (dm2) mutant mice and H-2b (C57BL/6) mice were nonresponders. Injections of various dosages of a S protein-derived, immunogenic, synthetic peptide into BALB/c mice by various routes did not prime CTL. After incorporation of S protein particles into IFA or aluminum hydroxide, these protein Ag lost their ability to specifically stimulate CTL in vivo. After priming of mice with S protein emulsified in IFA or adsorbed to aluminum hydroxide boost injections with native S protein particles were inefficient in stimulating a specific CTL response. These findings are of relevance for the design of synthetic subunit vaccines for which specific stimulation of CD8+ T effector functions is desired.lld:pubmed
pubmed-article:8301120pubmed:languageenglld:pubmed
pubmed-article:8301120pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8301120pubmed:citationSubsetAIMlld:pubmed
pubmed-article:8301120pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8301120pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8301120pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8301120pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8301120pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8301120pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8301120pubmed:statusMEDLINElld:pubmed
pubmed-article:8301120pubmed:monthFeblld:pubmed
pubmed-article:8301120pubmed:issn0022-1767lld:pubmed
pubmed-article:8301120pubmed:authorpubmed-author:ReimannJJlld:pubmed
pubmed-article:8301120pubmed:authorpubmed-author:SchirmbeckRRlld:pubmed
pubmed-article:8301120pubmed:authorpubmed-author:KuhröberAAlld:pubmed
pubmed-article:8301120pubmed:authorpubmed-author:JanowiczZ AZAlld:pubmed
pubmed-article:8301120pubmed:authorpubmed-author:MelberKKlld:pubmed
pubmed-article:8301120pubmed:issnTypePrintlld:pubmed
pubmed-article:8301120pubmed:day1lld:pubmed
pubmed-article:8301120pubmed:volume152lld:pubmed
pubmed-article:8301120pubmed:ownerNLMlld:pubmed
pubmed-article:8301120pubmed:authorsCompleteYlld:pubmed
pubmed-article:8301120pubmed:pagination1110-9lld:pubmed
pubmed-article:8301120pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8301120pubmed:meshHeadingpubmed-meshheading:8301120-...lld:pubmed
pubmed-article:8301120pubmed:meshHeadingpubmed-meshheading:8301120-...lld:pubmed
pubmed-article:8301120pubmed:meshHeadingpubmed-meshheading:8301120-...lld:pubmed
pubmed-article:8301120pubmed:meshHeadingpubmed-meshheading:8301120-...lld:pubmed
pubmed-article:8301120pubmed:meshHeadingpubmed-meshheading:8301120-...lld:pubmed
pubmed-article:8301120pubmed:meshHeadingpubmed-meshheading:8301120-...lld:pubmed
pubmed-article:8301120pubmed:meshHeadingpubmed-meshheading:8301120-...lld:pubmed
pubmed-article:8301120pubmed:meshHeadingpubmed-meshheading:8301120-...lld:pubmed
pubmed-article:8301120pubmed:meshHeadingpubmed-meshheading:8301120-...lld:pubmed
pubmed-article:8301120pubmed:meshHeadingpubmed-meshheading:8301120-...lld:pubmed
pubmed-article:8301120pubmed:meshHeadingpubmed-meshheading:8301120-...lld:pubmed
pubmed-article:8301120pubmed:meshHeadingpubmed-meshheading:8301120-...lld:pubmed
pubmed-article:8301120pubmed:meshHeadingpubmed-meshheading:8301120-...lld:pubmed
pubmed-article:8301120pubmed:meshHeadingpubmed-meshheading:8301120-...lld:pubmed
pubmed-article:8301120pubmed:meshHeadingpubmed-meshheading:8301120-...lld:pubmed
pubmed-article:8301120pubmed:meshHeadingpubmed-meshheading:8301120-...lld:pubmed
pubmed-article:8301120pubmed:meshHeadingpubmed-meshheading:8301120-...lld:pubmed
pubmed-article:8301120pubmed:year1994lld:pubmed
pubmed-article:8301120pubmed:articleTitleImmunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo.lld:pubmed
pubmed-article:8301120pubmed:affiliationInstitute for Microbiology, University of Ulm, Germany.lld:pubmed
pubmed-article:8301120pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8301120pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8301120lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8301120lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8301120lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8301120lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8301120lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8301120lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8301120lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8301120lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8301120lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8301120lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8301120lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8301120lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8301120lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8301120lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8301120lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8301120lld:pubmed